サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1428223

卵胞刺激ホルモン（FSH）の世界市場レポート 2024

Follicle Stimulating Hormone Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
卵胞刺激ホルモン（FSH）の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

卵胞刺激ホルモン（FSH）の市場規模は、今後数年間で着実に成長すると予想されています。 2028年には5.0%の年間複合成長率（CAGR）で24億9,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、治療用途の拡大、併用療法の需要の増加、効果的な避妊法のニーズの高まり、人口の高齢化とそれに関連するヘルスケア要件、主要地域での市場の拡大によるものと考えられます。予測期間中に予想される主な動向には、先進的なバイオシミラーFSH製品の開発、規制当局の承認と市場アクセス、FSHの生産と配送における技術の進歩、効果的な避妊薬の選択肢に対する需要の増加などが含まれます。

卵胞刺激ホルモン（FSH）市場の予想される成長は、不妊症の有病率の増加によって促進されると予想されます。男性または女性の生殖器系に影響を与える症状である不妊症は、12か月以上頻繁に無防備な性的接触を続けた後に妊娠できないことを特徴とします。卵胞刺激ホルモン（FSH）は、卵巣での卵子の発育を促進し、女性の月経周期を調節する上で重要な役割を果たします。男性の場合、精巣の成長を促進し、健康な精子細胞の発達をサポートすることで男性の生殖能力に不可欠なタンパク質の生成を助けます。特に、2023年 4月の時点で、世界保健機関は、世界中の成人の約6人に1人が不妊症に悩まされており、成人人口の約17.5%を占めていると報告しています。さらに、2023年10月のオーストラリア統計局のデータによると、2022年の出生記録は3%減少し、全体の出生率は女性1人あたり1.63人となることが示されています。したがって、不妊症の有病率の増加は、卵胞刺激ホルモン（FSH）市場の成長の原動力となっています。

生殖補助医療（ART）の導入の増加も、近い将来、卵胞刺激ホルモン（FSH）市場の成長に寄与すると予想されます。生殖補助医療（ART）には、従来の方法が効果がないと判明した場合に、個人またはカップルの妊娠を支援するために設計された医療手順または実践が含まれます。生殖補助医療における卵胞刺激ホルモン（FSH）の使用は、生殖の課題に直面している個人またはカップルの妊娠成功の可能性を高めることを目的とした確立された治療法です。注目すべきことに、疾病管理予防センターが2023年9月に発表したCDCの2021年不妊治療クリニック成功率報告書では、2021年に米国の453の登録クリニックで約238,126人が413,776回のARTサイクルを受けたことが明らかになった。これらの処置により、91,906人の生児出生と97,128人の新生児が誕生しました。したがって、生殖補助医療（ART）の導入増加が卵胞刺激ホルモン（FSH）市場の主要な原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018～2023年
  • 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の卵胞刺激ホルモン（FSH）市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 組換えFSH
  • 尿中FSH
  • 世界の卵胞刺激ホルモン（FSH）市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 不妊治療
  • 生殖補助医療（ART）
  • その他
  • 世界の卵胞刺激ホルモン（FSH）市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 不妊センター
  • 病院
  • その他

第7章 地域および国の分析

  • 世界の卵胞刺激ホルモン（FSH）市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の卵胞刺激ホルモン（FSH）市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 卵胞刺激ホルモン（FSH）市場の競合情勢
  • 卵胞刺激ホルモン（FSH）市場の企業プロファイル
    • Pfizer Inc.
    • Novartis AG
    • Abbott Laboratories
    • Sanofi SA
    • Boehringer Ingelheim GmbH

第31章 その他の大手および革新的な企業

  • Merck KGaA
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Intas Pharmaceuticals Ltd.
  • Cipla Ltd.
  • Ferring Pharmaceuticals Inc.
  • Lupin Limited
  • Zydus Lifesciences Limited
  • Livzon Pharmaceutical Group Inc.
  • Emcure Pharmaceuticals Ltd.
  • LG Chem's life sciences
  • IBSA Group
  • Bharat Serums and Vaccines Limited
  • Nihon Kohden Corp.
  • Anhui Anke Biotechnology Group Co. Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14067

Follicle-stimulating hormone (FSH) is a hormone secreted by the pituitary gland, playing a crucial role in sexual maturation and reproduction. It influences the functioning of the testicles and ovaries, particularly in regulating egg production in the ovaries and the menstrual cycle.

The primary types of follicle-stimulating hormones include recombinant FSH and urinary FSH. Recombinant FSH is a form of FSH produced using recombinant DNA technology, as opposed to being derived from natural sources such as urine. These hormones find application in various areas, including infertility treatment, assisted reproductive technology (ART), and other medical contexts. They are utilized by diverse end-users, including infertility centers, hospitals, and similar institutions.

The follicle stimulating hormone market research report is one of a series of new reports from The Business Research Company that provides follicle stimulating hormone market statistics, including follicle stimulating hormone industry global market size, regional shares, competitors with a follicle stimulating hormone market share, detailed follicle stimulating hormone market segments, market trends and opportunities, and any further data you may need to thrive in the follicle stimulating hormone industry. This follicle stimulating hormone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The follicle stimulating hormone market size has grown strongly in recent years. It will grow from $1.94 billion in 2023 to $2.05 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth observed in the historic period can be linked to a rise in the occurrence of hormonal disorders, an increased need for fertility treatment, the broadening of FSH indications, the introduction of new FSH products to the market, and an escalating demand for secure and efficient contraceptive alternatives.

The follicle stimulating hormone market size is expected to see steady growth in the next few years. It will grow to $2.49 billion in 2028 at a compound annual growth rate (CAGR) of 5.0%. The anticipated growth in the forecast period can be ascribed to the broadening of therapeutic applications, an increasing demand for combination therapy, a rising need for effective contraceptive options, the aging population and its associated healthcare requirements, and the expansion of the market in key regions. Major trends expected in the forecast period include the development of advanced biosimilar FSH products, regulatory approvals and market access, technological advancements in FSH production and delivery, and an increasing demand for effective contraceptive options.

The anticipated growth in the follicle-stimulating hormone market is expected to be propelled by the increasing prevalence of infertility. Infertility, a condition impacting the male or female reproductive system, is characterized by the inability to conceive after 12 months or more of frequent, unprotected sexual contact. Follicle-stimulating hormone plays a crucial role in encouraging egg development in the ovaries and regulating the menstrual cycle in females. In men, it promotes testicular growth and assists in the production of a protein essential for male fertility by supporting the development of healthy sperm cells. Notably, as of April 2023, the World Health Organization reported that infertility affected approximately 1 in 6 adults globally, accounting for around 17.5% of the adult population. Moreover, data from the Australian Bureau of Statistics in October 2023 indicated a 3% decrease in recorded births in 2022, with an overall fertility rate of 1.63 births per woman. Consequently, the increasing prevalence of infertility is a driving force behind the growth of the follicle-stimulating hormone market.

The rising adoption of assisted reproductive technology is also anticipated to contribute to the growth of the follicle-stimulating hormone market in the foreseeable future. Assisted Reproductive Technology (ART) encompasses medical procedures or practices designed to assist individuals or couples in conceiving when conventional methods prove ineffective. The use of follicle-stimulating hormone in assisted reproductive technology is a well-established therapy aimed at enhancing the chances of a successful pregnancy for individuals or couples facing reproductive challenges. Notably, the CDC's 2021 Fertility Clinic Success Rates Report, released by the Centers for Disease Control and Prevention in September 2023, revealed that approximately 238,126 individuals underwent 413,776 ART cycles at 453 registered clinics in the United States in 2021. These procedures resulted in 91,906 live births and 97,128 live-born infants. Therefore, the increasing adoption of assisted reproductive technology is a key driver for the follicle-stimulating hormone market.

Product innovations emerge as a prominent trend gaining traction in the follicle-stimulating hormone market. Major players in the market are strategically focusing on the development of innovative products to fortify their positions. For example, in August 2021, Merck Specialties Pvt. Ltd., a healthcare company based in India, introduced the Pergoveris Pen as part of efforts to enhance infertility treatment options. The Pergoveris Pen stands out as an innovative device that integrates recombinant follicle-stimulating hormone (FSH) and recombinant luteinizing hormone (LH) in a convenient, pre-filled format. Notably, it is the first pen injector to combine these hormones. Tailored for prescribed use by in vitro fertilization (IVF) specialists, the Pergoveris Pen provides a combination treatment solution specifically designed for women experiencing severe deficiencies in FSH and LH.

Major companies in the follicle-stimulating hormone market are also investing in the development of groundbreaking products such as estrogen-based pills to augment their product offerings and gain a competitive edge. Estrogen-based pills, containing the essential hormone for the growth and management of the female reproductive system, represent a notable innovation. In August 2022, Myovant Sciences Ltd., a UK-based biopharmaceutical company, and Pfizer Inc., a US-based pharmaceutical and biotechnology firm, announced the US Food and Drug Administration (FDA) authorization for MYFEMBREE (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) as a one-pill treatment. MYFEMBREE serves as a once-daily medication for the treatment of moderate to severe pain caused by endometriosis in premenopausal women for up to 24 months. Additionally, it is authorized for premenopausal women experiencing excessive menstrual bleeding due to uterine fibroids. Myovant and Pfizer intend to jointly market MYFEMBREE in the United States.

In November 2021, Organon, a healthcare company based in the United States, completed the acquisition of Forendo Pharma, a clinical-stage drug development company based in Finland, for an undisclosed amount. This acquisition is expected to enhance Organon's portfolio of women's health treatments, particularly in the domain of follicle-stimulating hormones.

Major companies operating in the follicle stimulating hormone market report are Pfizer Inc., Novartis AG, Abbott Laboratories, Sanofi S.A., Boehringer Ingelheim GmbH, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Cipla Ltd., Ferring Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Emcure Pharmaceuticals Ltd., LG Chem's life sciences, IBSA Group, Bharat Serums and Vaccines Limited, Nihon Kohden Corp., Anhui Anke Biotechnology Group Co. Ltd., Taj Pharmaceuticals Ltd., Genpharm Inc., Cadwell Laboratories Inc., Creative BioMart, Electrical Geodesics Inc., Lee Biosolutions Inc., Trumac Healthcare, Midas Pharma GmbH, Biogenix Inc. Pvt. Ltd., Shanghai Techwell Biopharmaceutical Co. Ltd.

North America was the largest region in the follicle stimulating hormone market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the follicle stimulating hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the follicle stimulating hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The follicle-stimulating hormone market consists of sales of luteinizing hormone (LH), chorionic gonadotropin (CG), and thyroid-stimulating hormone. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Follicle Stimulating Hormone Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on follicle stimulating hormone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for follicle stimulating hormone ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The follicle stimulating hormone market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Recombinant FSH; Urinary FSH
  • 2) By Application: Infertility Treatment; Assisted Reproductive Technology (ART); Other Applications
  • 3) By End-Users: Infertility Center; Hospitals; Other End-Users
  • Companies Mentioned: Pfizer Inc.; Novartis AG; Abbott Laboratories; Sanofi S.A.; Boehringer Ingelheim GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Follicle Stimulating Hormone Market Characteristics

3. Follicle Stimulating Hormone Market Trends And Strategies

4. Follicle Stimulating Hormone Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Follicle Stimulating Hormone Market Size and Growth

  • 5.1. Global Follicle Stimulating Hormone Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Follicle Stimulating Hormone Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Follicle Stimulating Hormone Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Follicle Stimulating Hormone Market Segmentation

  • 6.1. Global Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Recombinant FSH
  • Urinary FSH
  • 6.2. Global Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Infertility Treatment
  • Assisted Reproductive Technology (ART)
  • Other Applications
  • 6.3. Global Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Infertility Center
  • Hospitals
  • Other End-Users

7. Follicle Stimulating Hormone Market Regional And Country Analysis

  • 7.1. Global Follicle Stimulating Hormone Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Follicle Stimulating Hormone Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Follicle Stimulating Hormone Market

  • 8.1. Asia-Pacific Follicle Stimulating Hormone Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Follicle Stimulating Hormone Market

  • 9.1. China Follicle Stimulating Hormone Market Overview
  • 9.2. China Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Follicle Stimulating Hormone Market

  • 10.1. India Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Follicle Stimulating Hormone Market

  • 11.1. Japan Follicle Stimulating Hormone Market Overview
  • 11.2. Japan Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Follicle Stimulating Hormone Market

  • 12.1. Australia Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Follicle Stimulating Hormone Market

  • 13.1. Indonesia Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Follicle Stimulating Hormone Market

  • 14.1. South Korea Follicle Stimulating Hormone Market Overview
  • 14.2. South Korea Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Follicle Stimulating Hormone Market

  • 15.1. Western Europe Follicle Stimulating Hormone Market Overview
  • 15.2. Western Europe Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Follicle Stimulating Hormone Market

  • 16.1. UK Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Follicle Stimulating Hormone Market

  • 17.1. Germany Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Follicle Stimulating Hormone Market

  • 18.1. France Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Follicle Stimulating Hormone Market

  • 19.1. Italy Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Follicle Stimulating Hormone Market

  • 20.1. Spain Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Follicle Stimulating Hormone Market

  • 21.1. Eastern Europe Follicle Stimulating Hormone Market Overview
  • 21.2. Eastern Europe Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Follicle Stimulating Hormone Market

  • 22.1. Russia Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Follicle Stimulating Hormone Market

  • 23.1. North America Follicle Stimulating Hormone Market Overview
  • 23.2. North America Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Follicle Stimulating Hormone Market

  • 24.1. USA Follicle Stimulating Hormone Market Overview
  • 24.2. USA Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Follicle Stimulating Hormone Market

  • 25.1. Canada Follicle Stimulating Hormone Market Overview
  • 25.2. Canada Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Follicle Stimulating Hormone Market

  • 26.1. South America Follicle Stimulating Hormone Market Overview
  • 26.2. South America Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Follicle Stimulating Hormone Market

  • 27.1. Brazil Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Follicle Stimulating Hormone Market

  • 28.1. Middle East Follicle Stimulating Hormone Market Overview
  • 28.2. Middle East Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Follicle Stimulating Hormone Market

  • 29.1. Africa Follicle Stimulating Hormone Market Overview
  • 29.2. Africa Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Follicle Stimulating Hormone Market Competitive Landscape And Company Profiles

  • 30.1. Follicle Stimulating Hormone Market Competitive Landscape
  • 30.2. Follicle Stimulating Hormone Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Novartis AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sanofi S.A.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Boehringer Ingelheim GmbH
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Follicle Stimulating Hormone Market Other Major And Innovative Companies

  • 31.1. Merck KGaA
  • 31.2. Teva Pharmaceutical Industries Ltd.
  • 31.3. Sun Pharmaceutical Industries Ltd.
  • 31.4. Intas Pharmaceuticals Ltd.
  • 31.5. Cipla Ltd.
  • 31.6. Ferring Pharmaceuticals Inc.
  • 31.7. Lupin Limited
  • 31.8. Zydus Lifesciences Limited
  • 31.9. Livzon Pharmaceutical Group Inc.
  • 31.10. Emcure Pharmaceuticals Ltd.
  • 31.11. LG Chem's life sciences
  • 31.12. IBSA Group
  • 31.13. Bharat Serums and Vaccines Limited
  • 31.14. Nihon Kohden Corp.
  • 31.15. Anhui Anke Biotechnology Group Co. Ltd.

32. Global Follicle Stimulating Hormone Market Competitive Benchmarking

33. Global Follicle Stimulating Hormone Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Follicle Stimulating Hormone Market

35. Follicle Stimulating Hormone Market Future Outlook and Potential Analysis

  • 35.1 Follicle Stimulating Hormone Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Follicle Stimulating Hormone Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Follicle Stimulating Hormone Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer